Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
Spinraza treatment does not lead to significant kidney dysfunction in SMA patients with types 1 and 2, a safety and efficacy ...
This study aims to investigate the relationship between urinary creatinine (UCr) and the risk and severity of Diabetic Kidney ...
A groundbreaking study revealed that platelet distribution width (PDW) could be used as a useful non-invasive biomarker for ...
Examining the Relationship of Socioeconomic Factors in Disease Presentation and Progression,” published in the January 2025 ...
The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...
A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...
For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an ...
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...
Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, reinforcing its potential as an effective treatment option while also allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback